R&D Systems™ Recombinant Human CCL3L1/LD78 beta

Description

Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility. Applications: Bioactivity

The Recombinant Human CCL3L1/MIP-1 alpha Isoform LD78 beta is derived from E. coli. The Recombinant Human CCL3L1/MIP-1 alpha Isoform LD78 beta has been validated for the following applications: Bioactivity.

Specifications

• Formulation: Lyophilized from a 0.2μm filtered solution in Acetonitrile and TFA.
• Gene ID (Entrez): 6349
• Molecular Weight (g/mol): 7.8 kDa
• Name: CCL3L1/MIP-1 alpha Isoform LD78 beta
• Quantity: 25μg
• Source: E. coli-derived human CCL3L1/MIP-1 alpha Isoform LD78 beta protein Ala24-Ala93
• Storage Requirements: Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70° C as supplied. 1 month, 2 to 8° C under sterile conditions after reconstitution. 3 months, -20 to -70° C under sterile conditions after reconstitution.
• Conjugate: Unconjugated
• Recombinant: Recombinant
• Purity or Quality Grade: 97%, by SDS-PAGE under reducing conditions and visualized by silver stain.